Albert Wong, Hong Kong Science and Technology Parks CEO
Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader
Following the suit of AstraZeneca last February, Boehringer Ingelheim will team up with a leading R&D hub in Hong Kong to seed biotechs.
Whereas …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
